Concepedia

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

Unknown author(s)

The Lancet · 2001 · 764 citations · 7 references

DOIFull text

Open access

Concepts

References

7

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

Frans Van de Werf · The Lancet · 1999 · 880 citations

, , +7

1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations

Thomas J. Ryan, Elliott M. Antman, Neil Brooks et al. · Circulation · 1999 · 747 citations

, , +17

Abciximab Facilitates the Rate and Extent of Thrombolysis

Elliott M. Antman, Robert P. Giugliano, C. Michael Gibson et al. · Circulation · 1999 · 687 citations · Full text

, , +16

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Eric J. Topol · The Lancet · 2001 · 686 citations

, , +17

Trial of Abciximab With and Without Low-Dose Reteplase for Acute Myocardial Infarction

E. Magnus Ohman · Circulation · 2000 · 204 citations · Full text

, , +10